focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Jun 2013 12:25

RNS Number : 0866H
Akers Biosciences, Inc.
14 June 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

 

AKERS BIOSCIENCES INC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

CHUBEWORKX GUERNSEY LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14th June 2013

6. Date on which issuer notified:

14th June 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

24 %

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

COMMON STOCK

0

0

80,000,000

80,000,000

0

24.3%

0 %

USU009441051

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

80,000,000

24.3 %

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

 

 

14. Contact name:

DARREN JENKINS

15. Contact telephone number:

+447775007862

 

 

 

 

 

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Contact address

(registered office for legal entities)

 

Phone number & email

 

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGGUUPQUPWGGC
Date   Source Headline
22nd Nov 200512:00 pmRNSHolding(s) in Company
15th Nov 20055:22 pmRNSHolding(s) in Company
14th Nov 20057:01 amRNSChange of Adviser
3rd Nov 20054:50 pmRNSIssue of Equity
17th Oct 20056:00 amPRNAdditional Listing
12th Oct 20055:17 pmRNSHolding(s) in Company
5th Oct 20056:00 amPRNTrading and Financing Update
27th Sep 20056:00 amPRNInterim Results
19th Sep 20056:00 amPRNNotice of Results
9th Sep 20056:00 amPRNSuccessful Outcome Of Litigation
5th Sep 20056:00 amPRNRe Distribution Agreement
26th Jul 20056:00 amPRNBusiness Update
1st Jul 200512:39 pmRNSIssue of Shares
30th Jun 200511:44 amRNSAnnual Report and Accounts
27th Jun 20056:00 amPRNUK Distribution Update
23rd Jun 20053:12 pmRNSIssue of Equity
22nd Jun 20054:19 pmRNSIssue of Equity
27th May 20057:00 amRNSIssue of Shares
12th May 200512:13 pmRNSIssue of Shares
28th Apr 20056:00 amPRNFDA Product Clearance
27th Apr 200512:37 pmRNSIssue of Equity
27th Apr 200510:32 amRNSDirector Shareholding
12th Apr 20055:49 pmRNSIssue of Equity
12th Apr 20056:00 amPRNFinal Results
14th Mar 20057:00 amPRNFinancing Agreement
1st Mar 20057:00 amPRNFDA Review On Akers Product
22nd Feb 20057:00 amPRNRe. Distribution Agreement
16th Feb 20055:22 pmRNSIssue of Equity
14th Feb 20057:00 amPRNRe Agreement
26th Jan 20054:28 pmRNSIssue of Equity
14th Jan 20057:00 amPRNTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.